Skip to main content

Closed

NRXP: NRx Pharmaceuticals, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Revenue growth+0.0% / yr

Operating margin-749.7%

ROIC133.4%

Financially safe

Stretched

Debt / equity-0.07×

Interest coverage-19.0×

Current ratio0.29×

NRx Pharmaceuticals, Inc.

NRXPNASDAQ Global Market·USD·Closed

NRx Pharmaceuticals, Inc.

NRXPNASDAQ·USD·Closed

$3.15

+0.96%

$3.15

+$0.03 (0.96%)

52W Range

45thpctl

Volume

0.94×avg

Mkt Cap

54.45MUSD

P/E

-2.5TTM

Div Yield

–ann

52W Range

45thpctl

Volume

0.94×avg

Market Cap

54.45MUSD

P/E Ratio

-2.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings